![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Andrea Zanichelli, Vincenzo Montinaro, Massimo Triggiani, Francesco Arcoleo, Debora Visigalli & Mauro Cancian. (2022) Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency. Expert Opinion on Emerging Drugs 27:2, pages 103-110.
Read now
Read now
Andrea Zanichelli, Maddalena Alessandra Wu, Arnaldo Andreoli, Marta Mansi & Marco Cicardi. (2015) The safety of treatments for angioedema with hereditary C1 inhibitor deficiency. Expert Opinion on Drug Safety 14:11, pages 1725-1736.
Read now
Read now
Articles from other publishers (6)
Philip H. Li, Ruby Pawankar, Bernard Yu-Hor Thong, Jie Shen Fok, Hiroshi Chantaphakul, Michihiro Hide, Ankur Kumar Jindal, Hye-Ryun Kang, Amir Hamzah Abdul Latiff, Rommel Crisenio M. Lobo, Sonomjamts Munkhbayarlakh, Dinh Van Nguyen, Shyh-Dar Shyur, Yuxiang Zhi & Marcus Maurer. (2023) Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey. The Journal of Allergy and Clinical Immunology: In Practice 11:4, pages 1253-1260.
Crossref
Crossref
Qi Cui, Qingxiu Xu, Yaqi Yang, Wenjing Li, Nan Huang, Hao Chen, Dongxia Ma, Shuchen Zhang, Lin Yang & Rongfei Zhu. (2022) The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels. World Allergy Organization Journal 15:1, pages 100620.
Crossref
Crossref
Paula J. Busse, Sandra C. Christiansen, Marc A. Riedl, Aleena Banerji, Jonathan A. Bernstein, Anthony J. Castaldo, Timothy Craig, Mark Davis-Lorton, Michael M. Frank, H. Henry Li, William R. Lumry & Bruce L. Zuraw. (2021) US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology: In Practice 9:1, pages 132-150.e3.
Crossref
Crossref
Viviana Piras, Francisca Alves & Margarida Gonçalo. (2019) Self‐administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema. Dermatologic Therapy 32:6.
Crossref
Crossref
Daniel P. TeufelGavin BennettHelen HarrisonKaterine van RietschotenSilvia PavanCatherine StaceFrançois Le Floch, Tine Van Bergen, Elke Vermassen, Philippe Barbeaux, Tjing-Tjing Hu, Jean H. M. Feyen & Marc Vanhove. (2018) Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. Journal of Medicinal Chemistry 61:7, pages 2823-2836.
Crossref
Crossref
B. Paul Morgan & Claire L. Harris. (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nature Reviews Drug Discovery 14:12, pages 857-877.
Crossref
Crossref